|
|
Determining the clinical group,autoantibody status,and time from disease onset to diagnosis of patients with myositis provides useful information in predicting clinical responses to therapy,and these factors should be considered in designing future therapeutic trials.Methotrexate therapy may be superior to either azathioprine or further steroid treatment alone in certain patients who do not respond completely to an initial adequate course of prednisone. |
|